Botswana Vaccines Import Market -- HS Code 3002 Trade Data & Price Trend (Sep 2025)

Botswana Vaccines Import (HS 3002) Key Takeaways

Botswana’s Vaccines Import under HS Code 3002 in September 2025 reflects a dual market structure, with high-volume, low-cost veterinary vaccines dominating alongside premium human medical products commanding prices up to 7,248 USD/kg. The market rebounded sharply in value and pricing after mid-year volatility linked to US trade policy shifts, signaling resilience. Supplier concentration is extreme, with 98% of trade controlled by a handful of high-volume players, creating supply chain risks. South Africa supplies over half the volume but at lower value, while high-yield European markets like Ireland and France deliver premium products in smaller quantities. This analysis, covering September 2025, is based on cleanly processed Customs data from the yTrade database.

Botswana Vaccines Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood, vaccines, toxins, and cultures. This category is critical for healthcare, pharmaceuticals, and veterinary industries, driven by global demand for disease prevention and treatment. Vaccines, in particular, are a high-priority commodity due to their role in public health and biosecurity.

Current Context and Strategic Position

The U.S. Administration increased additional duties on all imports from Botswana to 37% effective 9 April 2025 [Global Trade Alert]. This policy shift underscores the need for vigilance in Botswana's vaccines import market, as higher tariffs could disrupt trade flows. Botswana's strategic significance in HS Code 3002 trade data lies in its role as a supplier of essential medical products, making market monitoring crucial amid evolving trade barriers. Stakeholders must assess the impact of these duties on Botswana's vaccine exports and global supply chains.

Botswana Vaccines Import (HS 3002) Price Trend

Key Observations

In September 2025, Botswana's vaccine imports reached 2.53 million USD at an average unit price of 129.11 USD per kilogram, reflecting a strong rebound in both value and pricing after a period of instability. This performance underscores a recovery in the hs code 3002 value trend, driven by renewed import activity.

Price and Volume Dynamics

The Botswana Vaccines Import trend exhibited significant volatility throughout 2025, with a sharp rise in March followed by a decline in April, coinciding with the US increase in duties on all imports from Botswana effective that month [Global Trade Alert]. This policy disruption likely compressed margins and altered supply patterns, contributing to erratic unit prices and volumes. The sequential recovery into September, with value up sharply from August, suggests market adaptation, possibly tied to seasonal health procurement cycles or diversified sourcing to mitigate trade barriers.

Botswana Vaccines Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

Botswana's HS Code 3002 import in September 2025 is heavily concentrated in veterinary vaccines, which account for 40% of the total import value. According to yTrade data, this product (30024200) moves in large volumes at a low unit price of 3.45 USD per kilogram, confirming its role as a high-volume, essential commodity. A notable anomaly is the human vaccine sub-code 30024127, which represents 43% of the quantity but only 8% of the value due to its minimal unit price, and is excluded from the main structural analysis.

Value-Chain Structure and Grade Analysis

The remaining imports under HS Code 3002 fall into two distinct categories. High-value human medicines, including vaccines and immunological products, command premium prices up to 7,248 USD per kilogram, indicating advanced manufacturing and specialized application. Mid-range blood fractions and antisera, with unit prices around 100 USD per kilogram, serve as intermediate biological products. This structure shows Botswana’s import mix spans from standardized veterinary commodities to highly differentiated human medical goods.

Strategic Implication and Pricing Power

Suppliers of high-value human medical products under HS Code 3002 hold significant pricing power due to their specialized nature and limited competition. For market players, the priority should be securing reliable access to these premium goods, while veterinary vaccine importers must focus on volume efficiency and cost management. Analysis of HS Code 3002 trade data confirms that market strategy must align with either high-margin specialization or high-volume commodity handling.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Vaccines Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

SOUTH AFRICA is the dominant source for Botswana's Vaccines imports in September 2025, accounting for 53.92% of the quantity and 52.25% of the shipment frequency. However, its value share is only 28.55%, which is lower than the quantity share. This gap suggests that Vaccines from South Africa are likely lower-value or bulkier items, such as generic versions or raw materials for HS Code 3002, rather than high-end products. The high frequency share aligns with regular, volume-driven shipments, possibly due to geographic proximity and established trade routes.

Origin Countries Clusters and Underlying Causes

The top origins form two main clusters based on share profiles. The high-yield cluster includes Ireland, France, and Denmark, where value shares are high (18.73%, 11.08%, and 9.95% respectively) but quantity shares are very low (under 0.26%). This indicates imports of premium, high-value Vaccines, likely from developed markets with advanced pharmaceutical industries. The volume cluster features South Africa and India, with high quantity shares (53.92% and 43.22%) but lower value shares, pointing to bulk supplies of cost-effective or generic vaccines, driven by production capacity and competitive pricing.

Forward Strategy and Supply Chain Implications

Botswana's heavy reliance on South Africa for volume in Vaccines imports under HS Code 3002 creates potential supply chain vulnerabilities, such as disruptions from regional issues. Diversifying sources towards high-yield clusters like European countries could improve quality assurance and reduce dependency. This shift would support a more stable and resilient supply chain for essential healthcare products, ensuring consistent access to varied vaccine types.

Table: Botswana Vaccines (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Vaccines (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In September 2025, the Botswana Vaccines Import suppliers market showed high concentration. According to yTrade data, a small set of high-value, high-frequency suppliers dominated, handling over 98% of the trade value and nearly all the quantity. This group typically engaged in frequent, large-volume transactions, making them the core of the import activity for vaccines.

Strategic Supplier Clusters and Trade Role

The remaining supplier clusters had minimal impact, with low-value, high-frequency players contributing only a small share of value. The dominant HS code 3002 suppliers, including manufacturers and logistics firms, point to a direct-to-factory sourcing model with some intermediation. This structure suggests that Botswana relies on established producers for vaccine imports, with limited diversity in supply sources.

Sourcing Strategy and Vulnerability

For importers in Botswana, the high supplier concentration requires a strategic focus on maintaining strong relationships with key partners to ensure supply continuity. The risk of disruption is significant due to dependency on few suppliers. External factors, such as the US increase in duties on imports from Botswana effective April 2025 [Global Trade Alert], add potential trade policy risks that could affect costs or availability, underscoring the need for contingency planning.

Table: Botswana Vaccines (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Vaccines Supplier lists

Action Plan for Vaccines Market Operation and Expansion

• Analyze hs code 3002 trade data to diversify sourcing beyond South Africa, targeting high-value European suppliers; this reduces supply chain vulnerability and secures access to premium products for the Botswana Vaccines Import market.
• Forge direct partnerships with high-frequency, high-value suppliers identified in the data to lock in reliable supply and mitigate the risk of disruption to the Vaccines supply chain.
• Segment procurement by product grade, using hs code 3002 trade data to source low-cost veterinary vaccines in bulk from volume clusters while prioritizing high-spec human vaccines from quality-assured partners.
• Monitor trade policy alerts and incorporate potential duty changes into cost models for the Botswana Vaccines Import strategy to avoid unexpected cost inflation and maintain budget predictability.
• Leverage shipment frequency data to optimize inventory cycles, preventing overstock of high-volume items and ensuring ready availability of high-value specialized goods within the Vaccines supply chain.

Take Action Now —— Explore Botswana Vaccines Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Vaccines Import 2025 September?

Botswana's vaccine imports rebounded in September 2025, reaching 2.53 million USD, after volatility caused by US trade policy disruptions in April. The recovery reflects market adaptation, likely due to seasonal procurement cycles or diversified sourcing to mitigate trade barriers.

Q2. Who are the main origin countries of Botswana Vaccines (HS Code 3002) 2025 September?

South Africa dominates with 53.92% of quantity but only 28.55% of value, while high-value vaccines come from Ireland (18.73% value), France (11.08%), and Denmark (9.95%).

Q3. Why does the unit price differ across origin countries of Botswana Vaccines Import?

Prices vary due to product specialization: bulk veterinary vaccines (low-value, e.g., 3.45 USD/kg) come from South Africa/India, while premium human vaccines (up to 7,248 USD/kg) are sourced from European countries.

Q4. What should importers in Botswana focus on when buying Vaccines?

Importers must prioritize securing high-value human medical products from reliable EU suppliers while managing cost efficiency for bulk veterinary vaccines. Diversifying sources reduces dependency on South Africa’s volume-driven supply.

Q5. What does this Botswana Vaccines import pattern mean for overseas suppliers?

European suppliers of high-value vaccines hold pricing power due to limited competition, while bulk producers (e.g., South Africa/India) must compete on volume and cost efficiency.

Q6. How is Vaccines typically used in this trade flow?

Vaccines under HS Code 3002 serve essential healthcare needs, ranging from mass veterinary immunization (low-cost, high-volume) to specialized human medical applications (high-value, low-volume).